← Leaderboards
Xu Han
Cryocrate, Llc
$9,225,517
Attributed
$9,371,998
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,371,998 · 9
By mechanism
R44$8,474,522 · 5
R43$604,513 · 3
R33$292,963 · 1
Top collaborators
- Xunlei Kang1 shared
Others in their field
Top investigators on “Devices”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$199,696,645
- David Heimbrook · Leidos Biomedical Research, Inc.$141,696,528
- Daniel Ernest Ford · Johns Hopkins University$129,841,670
- Richard A Gibbs · Baylor College Of Medicine$118,056,644
Research focus
DevicesTechnologyCryopreservationIn VitroProductionSafetyCellsTransplantationTissuesFutureIn VivoTissue DonorsLiquid SubstanceCollaborationsEngineeringSterilityPreservationNitrogenPreventBaseProtocols DocumentationBiomaterial CompatibilityPrototypeFeedback
Grant awards (15)
Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery$922,420
R44 · FY2025 · OD · contact PI
Novel Biocompatible, High-Throughput Cryopreservation Medium and Method for Enhanced Post-Thaw Migration and Cytotoxicity of NK Cells$292,963
R33 · FY2025 · CA · contact PI
Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery$940,821
R44 · FY2024 · OD · contact PI
Innovation of Biobanking for Cellular Adoptive Immunotherapies Based on a First-in-Class Biocompatible Cryopreservation Technology for T and NK Cells and Their CAR-Engineered Products$864,173
R44 · FY2023 · CA · contact PI
Innovation of Skin Banking and Transplantation Based on a First-in-Class Biocompatible Cryopreservation Technology$736,276
R44 · FY2023 · AI · contact PI
Innovation of Biobanking for Cellular Adoptive Immunotherapies Based on a First-in-Class Biocompatible Cryopreservation Technology for T and NK Cells and Their CAR-Engineered Products$898,913
R44 · FY2022 · CA · contact PI
Innovation of Skin Banking and Transplantation Based on a First-in-Class Biocompatible Cryopreservation Technology$751,525
R44 · FY2022 · AI · contact PI
Late-stage Preclinical Development and cGMP Production of a First-in-Class Cornea Cryopreservation Kit Based on FDA Feedback$726,985
R44 · FY2022 · EY · contact PI
Late-stage Preclinical Development and cGMP Production of a First-in-Class Cornea Cryopreservation Kit Based on FDA Feedback$753,985
R44 · FY2021 · EY · contact PI
An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues$751,085
R44 · FY2020 · OD · contact PI
An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues$313,256
R44 · FY2020 · OD · contact PI
A Novel Cryopreservation Technology for Large Skin Grafts to Facilitate Tissue Banking and Allograft Transplantations$160,371
R43 · FY2020 · AI · contact PI
An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues$815,083
R44 · FY2019 · OD · contact PI
In-Situ Cryopreservation Without Cryoprotectants$291,523
R43 · FY2018 · OD · contact PI
An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues$152,619
R43 · FY2015 · OD · contact PI